Evaluation of Insulin Sensitivity and β-Cell Function Indexes Obtained From Minimal Model Analysis of a Meal Tolerance Test
- Garry M. Steil1,
- Chi-min Hwu2,
- Robert Janowski1,
- Farzam Hariri2,
- Sujata Jinagouda2,
- Christine Darwin2,
- Sameh Tadros2,
- Kerstin Rebrin1 and
- Mohammed F. Saad2
- 1Medtronic MiniMed, Northridge, California
- 2Department of Medicine, School of Medicine, University of California at Los Angeles, Los Angeles, California
- Address correspondence and reprint requests to Garry M. Steil, Medtronic MiniMed, 18000 Devonshire St., Northridge, CA 91325. E-mail: garry.steil{at}Medtronic.com
Abstract
Modeling analysis of glucose, insulin, and C-peptide following a meal has been proposed as a means to estimate insulin sensitivity (Si) and β-cell function from a single test. We compared the model-derived meal indexes with analogous indexes obtained from an intravenous glucose tolerance test (IVGTT) and hyperglycemic clamp (HGC) in 17 nondiabetic subjects (14 men, 3 women, aged 50 ± 2 years [mean ± SE], BMI 25.0 ± 0.7 kg/m2). Si estimated from the meal was correlated with Si estimated from the IVGTT and the HGC (r = 0.59 and 0.76, respectively; P < 0.01 for both) but was ∼2.3 and 1.4 times higher (P < 0.05 for both). The meal-derived estimate of the β-cell’s response to a steady-state change in glucose (static secretion index) was correlated with the HGC second-phase insulin response (r = 0.69; P = 0.002), but the estimated rate-of-change component (dynamic secretion index) was not correlated with first-phase insulin release from either the HGC or IVGTT. Indexes of β-cell function obtained from the meal were significantly higher than those obtained from the HGC. In conclusion, insulin sensitivity and β-cell indexes derived from a meal are not analogous to those from the clamp or IVGTT. Further work is needed before these indexes can be routinely used in clinical and epidemiological studies.
- FFA, free fatty acid
- FSD, fractional SD
- HGC, hyperglycemic clamp
- IVGTT, intravenous glucose tolerance test
Footnotes
-
M.F.S. has received research support from Medtronic MiniMed.
-
- Accepted February 17, 2004.
- Received November 3, 2003.
- DIABETES











